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PURPOSE. A fish scale–derived collagen matrix (FSCM) is proposed as an alternative for human
donor corneal tissue. Light scatter and light transmission of the FSCM were measured and
compared with human cornea, and its short-term biocompatibility was tested in a rat model.
METHODS. Light scatter was determined with a straylight measuring device, whereas light
transmission was measured using a broadband absorption spectrometer. For evaluation of the
biocompatibiliy, three approaches were used: the FSCM was implanted as an anterior lamellar
keratoplasty (ALK), placed in an interlamellar corneal pocket (IL), and placed subconjunc-
tivally (SC). Transparency, neovascularization, and epithelial damage were followed for 21
days. Morphology and cellular infiltration were assessed histologically.
RESULTS. The amount of scattered light was comparable to that seen in early cataract and the
percentage of light transmission was similar to the transmission through the human cornea.
Implantation of the FSCM as an ALK led to mild haziness only, not obscuring the pupil, despite
the development of neovascularization around the sutures; IL placement led to a moderate
haze, partly obscuring the pupil, and to (partial) melting of the anterior corneal lamella. The
SC group exhibited local swelling and induration, which decreased over time. Histology
showed a chronic inflammation varying from mild and moderate in the ALK and IL group, to
severe in the SC group.
CONCLUSIONS. In spite of technical difficulties, it was feasible to use the FSCM for ALK, whereas
IL placement led to melting of the anterior lamella. Further studies are necessary for better
understanding of its immunogenicity. The light scatter and transmission data show that the
first version of this FSCM is comparable to human cornea tissue in this respect.
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Corneal disease is a major cause of blindness worldwide,second only to cataract. Globally, more than 10 million
individuals are bilaterally blind due to corneal pathology and
even more unilaterally.1 Corneal transplantation is presently the
only option to restore vision in these patients. Full-thickness
corneal transplantation is one of the most successful forms of
tissue transplantation and has been performed since 1905. One
year after transplantation, the success rate is excellent in low-
risk cases (avascular corneas). However, at longer follow-up,
the overall acceptance of the grafts declines, particularly in
high-risk cases.2–5 The worldwide demand for human donor
corneas, however, exceeds the world’s supply, especially in
developing countries.6 Artificial corneal substitutes have
emerged to counter this shortage and overcome the disadvan-
tages of human donor corneas, including immune rejection.
These corneal substitutes range from completely synthetic
prostheses, which primarily aim to restore the cornea’s
refractive function,7,8 and tissue-engineered cell-based con-
structs,9 to hydrogels and scaffolds that facilitate the regener-
ation of the host tissue.10–12
Although much progress has been realized, keratoprosthe-
ses have not reached widespread use.8 At the moment, they are
too expensive and complex for routine use in developing
countries, where the need for implants is highest. Alternatively,
biological explants are being developed and tissue-engineered
corneal epithelial cell sheets have been successfully transplant-
ed in patients.13–15 As corneal pathology often extends beyond
the epithelium and affects the corneal stroma as well,
replacement of the corneal stroma is usually necessary. To
replace the corneal stroma, a cell-based construct or polymer
scaffold of sufficient thickness is needed.
Ideally, such a scaffold for corneal regeneration allows
reepithelialization, endothelialization, and repopulation with
interstitial cells and nerves, preferably all of the patient’s own
origin. However, human corneal endothelium hardly regener-
ates. For many corneal opacities without endothelial involve-
ment, procedures that preserve the recipient’s endothelium are
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used, such as anterior lamellar keratoplasty (ALK) and deep
ALK (DALK). These anterior keratoplasties result in much
better graft survival than the full-thickness grafts in penetrating
keratoplasty (PK).16–18 The anterior lamellar approach is
therefore a logical starting point for scaffold-based corneal
regeneration. In 2010, this approach was studied with a
biosynthetic implant in a phase I clinical trial with 10 patients.
Corneal regeneration with restored vision and sensitivity was
found after 24 months of follow-up,19 proving potential of this
concept. The biosynthetic implant was synthesized from
human recombined collagen type I, which is an elaborate
and rather expensive procedure, and despite the claimed
success in this study, no new trials have started so far. Collagen
scaffolds that already exist in nature may reduce the cost of
fabrication and promise a sufficient resource for clinical
transplantation even in developing countries. A decellularized
porcine corneal matrix as a xenographic scaffold for corneal
regeneration has been studied for several years by several
research groups, as it closely resembles the human corneal
stromal organization.12,20,21 Indeed, such porcine matrices may
offer a relative inexpensive and widely available alternative to
human donor corneas. Results from clinical trials are not yet
available, but a first phase I clinical trial is currently running.22
Collagen matrices that are even more widely available, easier to
harvest, and at lower expense, therefore definitely offer an
interesting alternative, and this is the topic of our study.
Here we present the results of a matrix made from naturally
occurring collagen type I and obtained from scales of the
tilapia fish. Tilapia (Oreochromis mossambicus) are farmed for
consumption under controlled circumstances23 and the
specific size of the fish can be selected on harvesting. Their
scales consist of parallel-arranged collagen fibers packed in
layers oriented approximately 90 degrees,24 mimicking the
human corneal stroma. This scaffold supports the growth of
corneal cells and is highly permeable for oxygen.25 Moreover,
collagen sponges fabricated from reconstituted collagen fibers
from tilapia scales produce only rare inflammatory responses
in vivo.26
To investigate the suitability of this fish scale–derived
collagen matrix (FSCM) for use as an artificial cornea, the
light-scatter and light-transmission properties were examined.
Also, in vivo studies were performed, using the rat keratoplasty
model, widely employed for corneal transplantation studies.27
We investigated the short-term biocompatibility and handling of
the FSCM in three different surgical rat transplantation models.
METHODS
Fish Scale–Derived Artificial Cornea
A 6250-lm-thick decellularized and decalcified fish scale–
derived extracellular matrix (ECM), consisting of collagen type
I, was used for implantation (7-mm diameter, 0.2–0.3 mm
thickness, P09011001; Aeon Astron Europe, Leiden, The
Netherlands) (Fig. 1).25 In short, fresh tilapia scales were
cleaned in distilled water and cellular components were
removed using a four-step detergent and enzymatic extraction
process as developed by Courtman et al.28 Acetic acid was
used to increase pore size and porosity and nitric acid to
decalcify the fish scales. The decellularized and decalcified
scales were rinsed with 70% ethanol and stored until use in
sterilized PBS at 48C.
Top Pattern, Light Scatter, and Transmission
Phase-contrast images (Axio Observer.A1; Carl Zeiss AG, Jena,
Germany) were taken of the prepared fish scale–derived
collagen scaffold and used to create a composition photograph
in Adobe Photoshop (CS3 Extended, version 10.0; Adobe
Systems Incorporated, San Jose, CA) to visualize the whole top
surface. Scanning electron microscope images were taken of
the cutting edge of the prepared FSCM and of the micro
pattern on the top surface.
To measure forward light scatter, we chose a similar
approach as is used clinically to assess the functional effect
of forward light scatter in patients.29 This way, the ex vivo
results can directly be compared with clinical in vivo results.
We applied a psychophysical technique known as ‘‘compen-
sation comparison’’ and the outcome value is the straylight
parameter ‘‘s.’’30 This technique is implemented in a commer-
cial instrument (C-Quant; Oculus GmbH, Wetzlar, Germany) for
clinical use, measuring the light scatter between 5 and 10
degrees, which has proved representative for the total amount
of straylight (light scatter ‡1). We used this instrument, with a
slight adaption, to assess forward light scatter from physical
samples.31 In short, two stimuli of the compensation compar-
ison method, straylight flicker and comparison flicker, are
presented to and compared by the subject simultaneously. To
exclude the influence of light scatter provoked by the
observer’s eye and to measure only the light scatter caused
by the matrix, the straylight flicker source itself was shielded in
such a way that it illuminated only the tested sample.31 Three
FSCMs (P11251101; 8.0 6 0.8 mm [diameter], 0.25–0.35 mm
[thickness]) were put on a test glass, one drop of PBS was used
to prevent dehydration, and a cover glass was put on top. A
black, opaque disk, with a central hole of 6.5-mm diameter,
was mounted over the test glass, leaving only the FSCM visible.
The test glass, with the FSCM and black opaque disk, was put
in the ocular of the C-Quant device to measure the light scatter.
Three measurements per FSCM were performed. A holder
containing PBS without an FSCM acted as a control experi-
ment.
To measure light transmission, three FSCMs (P11251101;
8.0 6 0.8 mm [diameter], 0.25–0.35 mm [thickness]), placed
in a sample holder and kept hydrated with PBS, were studied
by a broadband absorption spectrometer, covering the visible
and near infrared spectrum with a spectral resolution of 0.55
nm. Details are available from Bouwman et al.32 The setup
comprised a light source (LOT Oriel Xe-arc; 300-lm filament;
LOT-QuantumDesign GmbH, Darmstadt, Germany) and spec-
trometer (Andor Shamrock SR-303i; Andor Technology PLC,
Belfast, UK). The light source emitted white light with a
homogeneous intensity pattern in the 200- to 760-nm region,
fully covering the wavelength domain relevant to the human
eye. This light was guided via a diaphragm through the center
of the FSCM, which was placed 15 cm from the 10-lm wide
inlet of the spectrometer. The sensor of the spectrometer
measured light only in the horizontal plane. The maximum
angle at which light could enter the spectrometer was 0.004
degrees. The spectrometer measured the direct light transmis-
sion, as straylight is defined as light being scattered at 1 or
more degrees. All measurements were taken relative to
FIGURE 1. The fish scale–derived collagen matrix.
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atmospheric air and normalized for background light. Normal-
ization and measurement of transmission values for empty
space were performed directly before each individual mea-
surement. A holder containing only PBS was used to correct for
light absorption or scatter caused by the holder itself. The light
transmission of the visible spectrum was measured in steps of
0.56-nm wavelength and compared with the total light
transmission of the human cornea, using the formula of van
den Berg and Tan.33
Suturing
Two human donor eyes, obtained from the Euro Cornea Bank
(Beverwijk, The Netherlands), were used to test the sutur-
ability of the scaffolds with nylon 10/0 sutures (nr. 8065
198001; Alcon B.V., Gorinchem, The Netherlands). In short,
two FSCMs of 6-mm diameter were sutured into human
corneas, 1 day postmortem, by placing 12 interrupted sutures
in one case and continuous suture in the other, including
knotting and burial of the knots. Severity of tearing due to the
suturing was observed.
Animals
Eighteen male Fischer 344/DuCrl albino rats (Charles River
Laboratory, L’Arbresle Cedex, France), each weighing between
280 and 336 g, were used for ocular implantation with
permission of the Animal Ethics Committee of the Leiden
University Medical Center. All animals were treated in
accordance with the ARVO Statement for Use of Animals in
Ophthalmic and Vision Research. They were given 1 week to
acclimatize.
Implantation
The rats were divided into three groups of six animals, and in
order to determine biocompatibility, scaffolds were placed in
the anterior eye. In the first group, the FSCM, with the pattern
on top, was placed as an ALK. In the second group, the FSCM
was placed in an intralamellar pocket (IL), and in the last group
it was inserted subconjunctivally (SC). The rats were anesthe-
tized with isoflurane, with the addition of a topical drop of
oxybuprocain and a subconjunctival injection of 20 lL
bupivacain. Prior to implantation, the FSCM was soaked for 5
minutes in antibiotics (polyspectran containing gramicidine,
neomycine, and polymyxine B).
ALK was performed by trephination of the right eye using a
3-mm trephine. The anterior tissue was removed using an air
bubble, lamellar dissector, and scissors. The FSCM was cut to a
diameter of 3.2 mm, inserted, and attached with eight nylon
10/0 sutures (nr. 8065 198001; Alcon B.V.). The surface of the
FSCM was carefully leveled to line up with the native
epithelium.
For the IL group, a nonpenetrating incision was made with
a 158 stab knife and a pocket was created using an air bubble
and a lamellar dissector. An FSCM with a diameter of 2.7 mm
was inserted and the pocket was closed with two 10/0 nylon
sutures.
SC implantation was performed by making an incision with
a 158 stab knife. A blunt spatula was used to create a
subconjunctival pocket, into which an FSCM with a diameter
of 2.7 mm was inserted; the pocket was closed with two 10/0
nylon sutures.
Dehydration of the eye during surgery was prevented by
regular wetting of the eye with special eye washings (balanced
salt solution, 907553; Pharmacy LUMC, Leiden, The Nether-
lands). Directly after surgery, 1% chloramphenicol ointment
(Chloramphenicol-POS 1%, 10 mg/g; Ursapharm Benelux B.V.,
Helmond, The Netherlands) was applied. In all cases, the
unoperated left eye served as a control and was kept hydrated
with gel (Vidisic Carbogel, carbomer 2 mg/g; Tramedico B.V.,
Weesp, The Netherlands) to prevent dryness during surgery.
In Vivo Observation
The animals were observed in the 3 weeks following
implantation. Ocular drops with corticosteroids and antibiotics
(Tobradex, containing dexamethasone and tobramycine; Alcon
Cusi SA, Barcelona, Spain) were applied in the ALK and IL
groups, once daily during the first week and every other day
during the second week. All drops were stopped at the 2-week
follow-up. The SC group did not receive any drops postoper-
atively.
At 2, 7, 13, and 21 days after implantation, all animals were
examined with a microscope to judge neovascularization,
transparency, and clinical signs of inflammation, such as
conjunctival redness or purulent secretion. Corneal neovascu-
larization was numerically scored from 0 to 5, with 0 ¼ no
vessels, 1 ¼ growth of vessels at the limbus, 2 ¼ vessels
reaching the sutures/FSCM, 3¼ vessels present underneath the
FSCM, 4 ¼ vessels entering the FSCM, and 5 ¼ vessels present
throughout the whole FSCM. Transparency of the cornea was
assessed using a grading scale as previously used by Hackett et
al.,34 with 0 ¼ transparent, 1 ¼ a mild haze not obscuring the
pupil, 2¼ a moderate haze partially obscuring the pupil, and 3
¼ an opaque area totally obscuring the pupil.
Histopathological Evaluation
After euthanizing the 16 rats with carbon dioxide, the eyes
were enucleated and fixated with Davidson solution (com-
posed of glacial acetic acid, ethyl alcohol, and buffered
formalin) and then dehydrated and embedded in paraffin.
Sections were cut on a microtome (Leica RM2165; Leica
Microsystems GmbH, Wetzlar, Germany) at 5 lm and stained
with hematoxylin and eosin (HE) for histological examination.
All eyes were analyzed for the organization of the epithelium,
stroma, and endothelium, and scored semiquantitatively for
infiltration of immune cells and ingrowth of corneal cells into
the FSCM. The immune infiltrate was characterized based on
morphology.
Statistical Analysis
All statistical analyses were performed using a statistical
software program (SPSS for Microsoft Windows, version
17.0.2; IBM SPSS Statistics, IBM Corporation, Chicago, IL).
The v2 trend test was used for assessing differences between
the groups regarding corneal neovascularization and opacifi-
cation, and leukocyte infiltration. Statistical significance was
assumed for resulting P values less than 0.05.
RESULTS
Top Pattern, Light Scatter, and Light Transmission
The whole top surface of the FSCM was visualized with a
composed phase-contrast image. The micro pattern on top of
the FSCM differed per area, with roughly one quarter having a
spider-web appearance with micro ridges and channels, two
quarters exhibiting circular running ridges and channels, but
without intersecting lines, and the last quarter consisting of
spikes (Fig. 2a). SEM images of the FSCM confirmed these
findings (Figs. 2b–d). The micro ridges were wavelike in shape,
65.7 lm high, and 63.4 lm wide. The channels in between
were indeed 630 lm wide (Fig. 3).25
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The amount of straylight was measured for three FSCMs
using the compensation comparison method. Log values for
forward light scatter caused by the holding device were
beyond the lowest measurable value for the C-Quant device
(log [s] < 0.40) and were considered to be negligible. The
mean light scatter of the three FSCMs was log (s) ¼ 1.62. All
results are listed in Table 1.
Direct light transmission of the visible spectrum was
measured on another three FSCMs. The mean direct light
transmission of the three measured FSCMs, corrected for
reduction of light transmission caused by the PBS-filled holder,
amounted to 89%, 97%, and 85% and showed corresponding
curved graphs (Fig. 4a). The three measurements were
grouped and compared with the total light-transmission curve
of the human cornea (Fig. 4b). The human corneal light-
transmission values were within the SEM of the FSCM light-
transmission values. The mean direct light transmission of the
FSCM was 90%, whereas the total light transmission of the
human cornea was 91%.33
Suturing
Suturing tests with the two FSCMs revealed in both methods
no tearing at the suture points and the knots could be buried.
On bringing in the suture needle, confined cracking occurred.
Micro-shearing at the suture points of the FSCM (and not of the
human cornea) was observed on tightening some of the knots.
Short-Term Biocompatibility
To determine the scaffold’s biocompatibility, FSCMs were
placed in the cornea as ALKs, placed intracorneally (intrala-
mellar pockets) and placed subconjunctivally.
One week following transplantation, all six rats that
underwent ALK had a clear and quiet cornea, with minimal
neovascularization in maximally one quadrant. After 2 weeks,
the scaffolds remained in place, while neovascularization was
reaching the FSCM. In five cases, a mild haze at the edge of the
FSCM, not obscuring the pupil, was observed, and in the sixth
animal, the haze partially obscured the pupil. Sutures started to
loosen slightly in all cases. At the 3-week end point, the
neovascularization extended underneath the FSCM with
vessels aimed at the sutures, but not penetrating the FSCM.
The haze increased slightly, not obscuring the pupil. Gradual
loosening of the sutures resulted in loss of the FSCM in two
cases at day 18 and 21, as the rats were allowed to move freely
and touch their eyes. These cases were excluded from further
analysis.
During follow-up, the eyes were stained with fluorescein to
analyze epithelialization. In the ALK group, the total area of the
FSCM stained positively, indicating the absence of reepitheli-
alization of the FSCM surface after 3 weeks.
Implantation in an intralamellar pocket was performed in
six rats. The results were less uniform than found for the ALK
implants. After 1 week, two cases showed no haze, two cases
exhibited a mild haze that did not obscure the pupil, and the
remaining two rats showed a moderate haze, partially
obscuring the pupil. In four cases, blood vessels approached
the sutures located near the limbus. All sutures were removed
after 1 week. After 2 weeks, superficial vessels reached the
FSCM. The amount of haze remained stable, while some
melting of the anterior lamella in front of the FSCM was
noticed in five animals. Two animals were killed at 13 and 19
days postimplantation due to too much weight loss. When the
3-week end point was reached, blood vessels reached the
FSCM in the remaining four animals, with some vessels starting
to invade the over- or underlying stroma. Vessels did not invade
the matrix and were less dense than in the ALK group.
After 3 weeks, the corneal haziness had slightly increased in
three animals, ranging from a mild haze to an opaque area
totally obscuring the pupil. In one case, however, the
neovascularization had diminished and remained present only
in the limbal area and a moderate corneal haze was observed.
FIGURE 2. Composition of several phase-contrast images showing the
distribution of the micro pattern with the spokes and interconnect-
ing channels in one quadrant (a-1), the spikes in the opposite quarter
(a-2), and the circular running lines in the area (a-3) between those
two quadrants. Detailed SEM-images depict the transitional area
between the circular lines and spikes (b), between the lines and
spokes (d), and a cross section showing the multiple layers (c).
FIGURE 3. Cross section of the FSCM showing the dimensions of the
circular running ridges on the surface.
TABLE 1. Forward Light Scatter Results in Log(s) With Oculus (C-
Quant)
Measurements First Second Third Mean
FSCM 1 1.50 1.53 1.46 1.50
FSCM 2 1.66 1.69 1.74 1.70
FSCM 3 1.62 1.65 1.63 1.63
Mean 1.62
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Corneal fluorescein staining revealed melted areas of the
anterior lamella of variable size in all four remaining cases.
The six rats receiving an SC implant showed slight SC
swelling postoperatively at the implantation site. The swelling
disappeared after 2 weeks in four rats and lasted until the end
point in two rats. Local conjunctival hyperemia was present at
a low degree until the end point. Sutures were not removed, as
within 1 week the sutures were overgrown by the conjunctiva
and removal without damaging the surrounding area proved to
be difficult.
Overall
Except for the two cases mentioned, all implanted animals
were in good health, kept their weight, and showed no
symptoms of any ocular infection or noticeable irritation. The
FSCM flattened the recipient rat cornea due to a curvature
disassociation. End point neovascularization and opacification
(Figs. 5a, 5b) did not differ significantly (P¼ 0.46 and P¼ 0.19,
respectively) between the ALK and IL groups. Typical cases of
each implantation model are depicted in Figure 6. An overview
of in vivo and histological characteristics is given in Table 2.
Histopathological Evaluation
To visualize the clinically observed changes with histology,
sections of the four scaffold-containing corneas in the ALK
group were cut, stained with HE, and compared with the
control lateral eye (Figs. 7a, 7b). HE staining showed mild
corneal edema with blood vessels and infiltrating leukocytes in
the stroma around the sutures and at a lower degree under the
FSCM (Figs. 7c, 7d). A few leukocytes were seen within the
FSCM. The leukocytes showed a typically chronic inflammato-
ry reaction with mainly macrophages and lymphocytes and
some neutrophils. Epithelial downgrowth occurred in all cases
at the border of the FSCM. At the location of the sutures and at
the border of the FSCM, the epithelium showed hyperplasia
and metaplasia.
HE staining of the four cases of the IL group showed
infiltration of immune cells, which consisted of the typical
mixture with macrophages, lymphocytes, and some neutro-
phils. A few leukocytes were found within the FSCM (Fig. 7e).
Local edema, metaplasia, and necrotic cells of the epithelium
overlying the FSCM were observed in three of the four cases
(Figs. 7e, 7f). However, one of the implants had no leukocytes
or blood vessels infiltrating the stroma (Fig. 7f) and the other
only a few (not shown). This corresponded with the in vivo
observations (Figs. 6f–j). Infiltration of immune cells was not
significantly different between the ALK and IL groups (P ¼
0.57) (Fig. 8).
The SC implants were completely surrounded by leukocytes
in all six cases, with several leukocytes invading the FSCM. The
leukocyte infiltration was limited to the adjacent surrounding
tissue, again representing chronic inflammation. The SC group
showed significantly more infiltration than the ALK group (P¼
0.04) and the IL group (P¼0.02) (Fig. 8). The tissue surrounding
the implant showed edema (Figs. 7g, 7h). Compared with
nonoperated control eyes, more vessels were present.
DISCUSSION
Pattern and Light Scatter and Transmission
The composed phase-contrast image of the FSCM shows that
the pattern that contains the micro channels covers only a
quarter and not the full surface. This is in accordance with the
natural pattern of the so-called ctenoid fish scales.35 Neverthe-
less, this nonhomogeneity of the pattern does not prevent
corneal stromal cells from populating the scaffold’s surface,
and is perhaps even stimulating cell spread.25 The circular
running ridges had a height and width much larger than the
visible wavelengths, thereby provoking light scatter. This is in
FIGURE 4. Direct light-transmission curves for the visible spectrum of three FSCMs (a), and the mean direct light transmission of the FSCM
compared with the total light transmission of the human cornea (b). HC, human cornea.
FIGURE 5. Scoring of corneal neovascularization (a) and opacification (b) at different time points during follow-up of the ALK and IL groups. Vessel
score and opacity score did not differ significantly at the 21-day end point (respectively P¼ 0.46 and P¼ 0.19; v2 trend test). Greatest difference of
vessel score between the two groups at day 13 was not significant either (P¼0.14). Error bars represent SEM. Vessel score: 0¼none; 1¼ at limbus;
2¼ reaching sutures /FSCM; 3¼under FSCM; 4¼ entering FSCM; 5¼whole FSCM. Opacity score: 0¼ transparent; 1¼mild haze, not obscuring the
pupil; 2 ¼moderate haze partially obscuring the pupil; 3 ¼ opaque area totally obscuring the pupil.
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accordance with the observations that the pattern was clearly
visible under the phase-contrast microscope. The latter
visualizes differences in refraction, which may cause light
scattering.
The FSCM had a forward light scattering of log(s) ¼ 1.62,
comparable to the amount of scattering caused by early
cataract.30,36 The direct light transmission was 90%. Even
though this value reflects the direct transmission and not the
total light transmission, which includes forward-scattered light
as well, it is very close to the total light transmission of 91%
found for the human cornea. The light-transmission curves of
the FSCM and human cornea are also very similar in shape,
indicating corresponding values of Rayleigh scatter (i.e., light
scatter caused by particles much smaller than the wavelength
of light such as molecules). The displacement along the y-axis
of the light-transmission curves for the different FSCMs can be
attributed to a wavelength-independent scatter, plausibly
caused by the micro pattern that roughens the surface of the
FSCM with ridges larger in size than the wavelength of visible
light. Although special care was taken for optimum position, it
could not be prohibited that each FSCM was slightly differently
positioned relative to the spectrometer and therefore caused
different amounts of scatter. Removal of the micro pattern
from the FSCM surface will improve light transmission and
especially light-scatter values, which in turn will result in
better visual acuity when implanted.
Suturing
The suturing test demonstrated that the FSCM can be sutured
successfully into the cornea, when handled with care. The
scaffold was brisker and had less mechanical strength than the
human cornea (or rat cornea), indicated by the confined cracking
and shearing. Increasing the elasticity and strength likely will
improve the ease of handling and this may be needed to make the
FSCM applicable for full-thickness transplantation in humans.
In Vivo Biocompatibility
The rat keratoplasty model has been used to study corneal
transplantation for more than 25 years.27 Our findings of this
first in vivo study with the FSCM correspond to the results seen
with allogeneic corneal transplantations in rats.37–39 All corneal
implants showed good acceptance up to 1 week postopera-
tively with neovascularization limited to one quadrant of the
limbal rim, no opacity at all in the ALK group, and mild opacity
in the IL group. After 3 weeks, neovascularization had
FIGURE 6. Typical cases of each implantation model are shown. The IL group has been separated in best result and average result, due to high
variability. All groups showed good transparency of the corneal implants on microscopic examination directly postoperatively (first column: [a, f, k,
p]) and up to 7 days (second column: [b, g, l, q]). Neovascularization and opacification were visible at 13 days (third column: [c, h, m, r]) and
gradually increased until day 21 (fourth column: [d, i, n, s]). Neovascularization is seen even more clearly postmortem (last column: [e, j, o, t]).
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increased until it reached the FSCM and sutures, but vessels
failed to penetrate the FSCM. The opacity gradually increased
to a mild haze (stage 1) in the ALK group and a moderate haze
(stage 2) in the IL group. Total opacification (stage 3) of the
FSCM, indicative for a complete rejection, was observed in only
one animal of the IL group. It is important to note that in
humans with a nonvascularized cornea, a non-HLA–matched
allogeneic corneal transplantation has a high acceptance rate,
whereas in rats, this situation leads to rejection after 5 to 15
days.37–39 A rejected graft is recognized by complete corneal
opacification and infiltrating T cells on histology. The main
finding of this study on the short-term biocompatibility and
handling of the FSCM to obtain a first impression of its use as a
replacement of human donor material, is that the FSCM may
have potential for corneal applications in humans.
The local abnormalities that occurred in the corneal
epithelium are largely explained by mechanical irritation
induced by the FSCM. The edges were standing out due to a
relative mismatch in curve and thickness and insufficient
elasticity. This led to compression of the overlaying stroma and
epithelium and created a tear meniscus in the IL group. These
characteristics also explain the development of epithelial
downgrowth that occurred in the ALK group. The dense
structure and thickness of the FSCM may have put pressure on
the remaining corneal tissue in the IL group, prohibiting
adequate flow of nutrients from the anterior chamber toward
the overlaying anterior cornea. This mechanism, together with
a too shallow implantation, is thought to be responsible for the
observed melting. Histology confirmed that the cases with
lesser melting were indeed implanted at a greater depth.
The amount of neovascularization was comparable to that
seen in allogeneic corneal transplantations in rats38,40 and
provoked by the sutures.41 This explains the higher degree of
neovascularization in the ALK group, in which more sutures
were used and not removed, in contrast to the IL group, in
which two sutures were used and removed after 2 weeks. In
both groups, vessels failed to invade the FSCM, perhaps due to
the fibril density of the FSCM or by yet to be identified
antiangiogenic properties.
Corneal opacification, which indicates swelling or an
ongoing immune reaction, reached levels compatible with a
complete rejection in 2 of the 12 corneal implants. The
observed opacification may be due to the mentioned
mechanical irritation, which leads to corneal damage and
subsequent leukocyte infiltration.
The infiltration of leukocytes was mild to moderate and
consisted predominantly of macrophages, lymphocytes, and
some neutrophils, indicative of a chronic immune reaction.
The leukocytic infiltration was primarily aimed at the sutures in
the ALK group and surrounded the scaffold in the SC group
and partly in the IL group. The SC group showed the presence
of fibroblasts aligned around the scaffold, similar to a mild
foreign body reaction.42 It is unlikely that this infiltration and
swelling is caused by pathogens present on the FSCM prior to
implantation, as FSCMs from the same batch were tested and
found to be negative for bacteria and fungi. Furthermore, a
more severe reaction is expected in case of infection. Type 1
collagen of fish is similar to that of humans43 and reconstituted
tilapia collagen sponges caused only rare inflammatory
responses.26 Still, the collagen of the FSCM or residues of
chemicals used for decellularization and decalcification could
have provoked the immune response. A strong argument to
support the notion that the inflammation was due to surgical
trauma and mechanical irritation is the complete absence of
inflammation in one case. If the inflammation had been due to
a heterologous protein, one would have expected an immune
response in all cases. The gradual tearing of the sutures
through the FSCM, as noticed after 2 weeks, was aggravated by
the outstanding edges and additional external mechanical
forces caused by blinking and eye movements. Placing a
contact lens or increasing the elasticity or curvature of the
FSCM may offer a pathway to prevent this.44 The increased
cellular infiltration and swelling on the histology of the SC
group is well explained by the less immune privilege of the
conjunctiva compared with the cornea.



























ALK 1 21 N 2 1 N – þþþ þ Y þþ
ALK 2 21 N 3 3 N þ þþ þ Y þþþ
ALK 3 21 N 3 1 N þ þþ þ Y þ
ALK 4 21 Y 3 0 N N/A N/A N/A N/A N/A
ALK 5 21 N 3 2 N þ þþ þþ Y þþ
ALK 6 18 Y – – Y N/A N/A N/A N/A N/A
IL 1 13 Y – – Y N/A N/A N/A N/A N/A
IL 2 13 N – – Y N/A N/A N/A N/A N/A
IL 3 21 N 3 2 N þ þþ þ N þþ
IL 4 21 N 2 2 N þþ þþ þ N –/þ
IL 5 21 N 3 3 N þ þ þ N þþ
IL 6 21 N 1 2 N þþ þ þþ N –
SC 1 21 N 0 0 N N/A N/A N/A N/A þþþ
SC 2 21 N 0 0 N N/A N/A N/A N/A þþþ
SC 3 21 N 0 0 N N/A N/A N/A N/A þþþ
SC 4 21 N 0 0 N N/A N/A N/A N/A þþþ
SC 5 21 N 0 0 N N/A N/A N/A N/A þþþ
SC 6 21 N 0 0 N N/A N/A N/A N/A þþþ
Epith., epithelial; N, no; N/A, not applicable; Y, yes; – ¼ absent,þ¼mild,þþ¼moderate, þþþ¼ severe.
Corneal vessel score: 0 ¼ none; 1¼ at the limbus; 2 ¼ reaching sutures/FSCM; 3¼ under FSCM; 4 ¼ in FSCM; 5 ¼whole FSCM.
Opacity score: 0 ¼ transparent; 1 ¼mild haze, not obscuring the pupil; 2 ¼ moderate haze partially obscuring pupil; 3 ¼ opaque area totally
obscuring pupil.
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Other collagen matrices used for corneal regeneration, such
as the biosynthetic artificial cornea,19 are already being used in
clinical studies, following a decennium of preclinical research.45
The novelty and advantage of the FSCMs are its wide availability,
its low cost, and simple manufacturing process. However, we are
at an early phase in our research, and working on overcoming
technical challenges so as to develop a useful prototype.
CONCLUSION
This systemic study of the physical and biomedical short-term
effects of the FSCM as corneal replacement, demonstrates its
potential for future use. The availability of an easy obtainable
and biocompatible FSCM can have a high impact on decreasing
the shortage of donor corneas and make lifelong use of
FIGURE 7. HE stainings. Examples of control corneas are shown (a, b). The ALK group had mild to moderate infiltration of leukocytes, epithelial
hyper- and metaplasia, and epithelial downgrowth due to mismatch in shape (c, d). The IL group had a mild to moderate infiltration in two cases (e)
and almost no infiltration in two other cases (f); all IL cases showed local atrophy and metaplasia of the epithelium (e, f). The SC group showed
moderate infiltration (g, h), with fibrous capsule formation and some leukocytes infiltrating between the layers (h). *Leukocyte infiltration and
concomitant edema.
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immunosuppressive medication redundant. The potential of
this FSCM is demonstrated for the first time by an adequate
light transmission, reasonable light-scattering values, and
ability to be used in keratoplasty. Future studies with a curved
and thinner FSCM are necessary to prevent mechanical
irritation and increase the understanding of its immunogenic-
ity. Long-term in vivo studies and studies on modified FSCMs,
for instance with the top pattern removed, are needed to
develop and optimize this readily available collagen matrix as
an artificial cornea.
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